CN104013993A - 一种具有诱导基因表达的骨生物修复制剂的制备方法 - Google Patents
一种具有诱导基因表达的骨生物修复制剂的制备方法 Download PDFInfo
- Publication number
- CN104013993A CN104013993A CN201410104328.8A CN201410104328A CN104013993A CN 104013993 A CN104013993 A CN 104013993A CN 201410104328 A CN201410104328 A CN 201410104328A CN 104013993 A CN104013993 A CN 104013993A
- Authority
- CN
- China
- Prior art keywords
- preparation
- bone
- toothpaste
- medical
- hydroxyapatite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 230000014509 gene expression Effects 0.000 title claims abstract description 10
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 12
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 239000000292 calcium oxide Substances 0.000 claims description 9
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 9
- 230000001939 inductive effect Effects 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 229910004298 SiO 2 Inorganic materials 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 235000019738 Limestone Nutrition 0.000 claims description 4
- 230000032683 aging Effects 0.000 claims description 4
- 239000006028 limestone Substances 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 3
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- 229960004998 acesulfame potassium Drugs 0.000 claims description 3
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 3
- 239000000619 acesulfame-K Substances 0.000 claims description 3
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 claims description 3
- 229960001631 carbomer Drugs 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 238000003837 high-temperature calcination Methods 0.000 claims description 3
- 229920001684 low density polyethylene Polymers 0.000 claims description 3
- 239000004702 low-density polyethylene Substances 0.000 claims description 3
- 239000013521 mastic Substances 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 235000011837 pasties Nutrition 0.000 claims description 3
- 229910052697 platinum Inorganic materials 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 3
- 239000004408 titanium dioxide Substances 0.000 claims description 3
- 229940034610 toothpaste Drugs 0.000 abstract description 31
- 239000000606 toothpaste Substances 0.000 abstract description 31
- 230000008439 repair process Effects 0.000 abstract description 16
- 208000014674 injury Diseases 0.000 abstract description 9
- 239000000463 material Substances 0.000 abstract description 9
- 210000001519 tissue Anatomy 0.000 abstract description 9
- 208000002925 dental caries Diseases 0.000 abstract description 7
- 208000027418 Wounds and injury Diseases 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 210000004204 blood vessel Anatomy 0.000 abstract description 4
- 210000003734 kidney Anatomy 0.000 abstract description 4
- 210000004185 liver Anatomy 0.000 abstract description 4
- 239000012567 medical material Substances 0.000 abstract description 4
- 210000002200 mouth mucosa Anatomy 0.000 abstract description 4
- 210000000578 peripheral nerve Anatomy 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 4
- 230000008929 regeneration Effects 0.000 abstract description 4
- 238000011069 regeneration method Methods 0.000 abstract description 4
- 210000002435 tendon Anatomy 0.000 abstract description 4
- 239000012620 biological material Substances 0.000 abstract description 3
- 230000006378 damage Effects 0.000 abstract description 3
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 208000007565 gingivitis Diseases 0.000 description 17
- 230000000694 effects Effects 0.000 description 10
- 238000011160 research Methods 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 6
- 230000008733 trauma Effects 0.000 description 6
- 206010018276 Gingival bleeding Diseases 0.000 description 5
- 208000024283 Gingival haemorrhages Diseases 0.000 description 5
- 210000004195 gingiva Anatomy 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 238000007689 inspection Methods 0.000 description 5
- 230000006872 improvement Effects 0.000 description 4
- 208000002064 Dental Plaque Diseases 0.000 description 3
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 230000003442 weekly effect Effects 0.000 description 3
- 229910014497 Ca10(PO4)6(OH)2 Inorganic materials 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000002178 crystalline material Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 208000028169 periodontal disease Diseases 0.000 description 2
- 201000001245 periodontitis Diseases 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 210000004357 third molar Anatomy 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 208000035126 Facies Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 208000005888 Periodontal Pocket Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- MWKXCSMICWVRGW-UHFFFAOYSA-N calcium;phosphane Chemical compound P.[Ca] MWKXCSMICWVRGW-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 208000004042 dental fluorosis Diseases 0.000 description 1
- 230000037123 dental health Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- MPNNOLHYOHFJKL-UHFFFAOYSA-N peroxyphosphoric acid Chemical compound OOP(O)(O)=O MPNNOLHYOHFJKL-UHFFFAOYSA-N 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种具有诱导基因表达的骨生物修复制剂的制备方法。制得的生物材料可用于制造生物骨修复牙膏、组织工程再生、创伤修复医用材料等。特别是在:组织工程骨、周围神经、血管、肌腱、体外人工肝人工肾装置、组织工程口腔粘膜,骨修复材料,预防龋齿、牙齿松动、牙龈出血、牙齿修复,创伤修复等方面的有着重大的科学价值和意义,为人类组织再生工程作出重大贡献。
Description
技术领域
本发明涉及一种具有诱导基因表达的生物修复制剂的制备方法,特别涉及一种长期持续使用可解决骨修复等问题的生物活性制剂。本发明的产品可用于制造生物骨修复牙膏、组织工程再生、创伤修复医用材料等。可广泛的应用在:组织工程骨、周围神经、血管、肌腱、体外人工肝人工肾装置、组织工程口腔粘膜,骨修复材料,预防龋齿、牙齿松动、牙龈出血、牙齿修复,创伤修复等方面的广泛应用。
背景技术
一、牙膏市场:
当今中国牙膏市场中,每年我国共生产牙膏约80亿标准支(65克包装),实现总产值140亿元。我国牙膏的市场容量应在220亿元至240亿元之间,还有近1/3的功能性牙膏市场没开发。
牙膏的类型不外乎这四大类:脱敏牙膏,争对牙齿敏感的人群;第二类:防龋齿,儿童面临酸性饮食环境,对蛀牙的伤害。第三类:药物类牙膏,针对牙周炎等不同的病状;简单止血功能,无法修复受损牙齿部分。第四类:是美白、清新口气,只起到清洁作用。
中国人口老龄化严重,牙齿松动、牙龈出血等口腔疾病比较普遍;儿童防蛀,主要加入含氟牙膏,在地中海性质区域,造成大量氟斑牙。
二、组织工程应用:
目前组织工程应用主要出现:合成材料,高分子人工合成材料PLA PGAPLGA,钙磷类人工合成陶瓷材料TCP HAP CPC BGC,复合材料PLA+HAP/TCP/CPC等生物材料的研究。
创伤市场目前主要靠以猪皮为原料,制造人工植皮技术,有生物免疫原性的副作用。
骨修复材料,主要来源有同种异体骨,人工骨等材料。远远无法满足医学发展的需要。
发明内容
针对上述问题,本发明提供一种本发明涉及一种具有诱导基因表达的生物修复制剂的制备方法。该产品可用于制造生物骨修复牙膏、组织工程再生、创伤修复医用材料等。可广泛的应用在:组织工程骨、周围神经、血管、肌腱、体外人工肝人工肾装置、组织工程口腔粘膜,骨修复材料,预防龋齿、牙齿松动、牙龈出血、牙齿修复,创伤修复等方面的广泛应用。
本发明的制剂的制备方法包括如下步骤:
(1)制备氧化钙:取石灰石在铂金罐中密封,在1900℃的条件下高温煅烧,冷却后经粉碎成为10-20nm的CaO粉末;
(2)生成具有生物活性的羟基磷灰石:取规格为10-20nm的CaO和P2O5纳米粉末,按照质量比1∶1.67混合均匀(500g),在36-38℃的情况下,无光条件下陈化至少12小时;加入医用纯净水500g搅拌成糊状,随后加入Na2O2(3g)38℃下搅拌45分钟,过10-20目筛,得到粒径为10-20nm的羟基磷灰石Ca10(PO4)6(OH)2(HA);
(3)向步骤(2)所得羟基磷灰石中加入SiO2(5g)混合均匀后,在-15~-20℃下冻干机冷冻干燥成粉末,并加入医用甘油10g、医用聚乙二醇10g、医用级钛白粉3g、香精1g、卡波姆2-3g、AK糖3g和十二烷基硫酸钠2g,均匀混合;
(4)灭菌:将步骤(3)混合所得膏状体在10℃条件下,辐照灭菌2小时;
(5)干燥:将步骤(4)所得生物制剂,在-15℃条件下冻干成固体状;
(6)粉碎:将该固体粉碎成为20nm的粉末状。
(7)包装:将灭菌膏体灌装在无菌低密度聚乙烯管内,每管质量为60g。
其中,SiO2与Ca10(PO4)6(OH)2形成具有三维网状生物多孔结构的无机矿物质。SiO2与Ca10(PO4)6(OH)2与唾液中的H2O发生迅速的反应,PH值在7.5左右,合成具有诱导基因表达能力的羟基磷灰石。释放Ca离子和P离子,从而补充损伤骨结构矿物质,产生沉积在受损骨创面之上和之内的稳定的结晶状羟基磷酸盐灰石层(矿化),促使骨组织生长,抑制和杀灭细菌,诱导新的新生组织形成,同时杀菌等作用也能有效缓解创伤发炎肿胀等症状。
诱导基因表达能力:
普通的羟基磷灰石仅仅可以修复,不具有诱导基因表达能力,细胞组织不能有序排列。而本发明的材料形成无水无机矿物,该矿物质具有三维的网状多孔结构,其深入损伤部分深处的细胞和毛细血管沿着与人体骨骼和组织相一致的孔装结构中,有序生长,再生细胞爬行在三维网状结构中。让新生组织有序的排列,具有基因的表达的能力。
生物降解,爬行替代:
本发明的材料在组织再生后,原三维多孔结构无机矿物质。新生组织在30日内,逐步爬行替代原结晶矿物质,原结晶矿物质降解为二氧化碳和水,随毛细血管排出。其新生组织恢复为原有形状。
本发明的材料可用于制造生物骨修复牙膏、组织工程再生、创伤修复医用材料等。特别是在:组织工程骨、周围神经、血管、肌腱、体外人工肝人工肾装置、组织工程口腔粘膜,骨修复材料,预防龋齿、牙齿松动、牙龈出血、牙齿修复,创伤修复等方面的有着重大的科学价值和意义,为人类组织再生工程作出重大贡献。
附图说明
图1是X射线下的新生羟基磷灰石成像图。
图2是牙齿骨修复后的效果图。
图3是骨修复效果图。其形成的三维多孔网状结构,和人体结构基本一致。
图4是骨关节软组织的修复效果图。
图5是对软组织的修复作用。其中,诱导组为使用本发明的产品的结果图。
具体实施方式
以下实施方式仅用于阐述本发明,而本发明的保护范围并非仅仅局限于以下实施例。所述技术领域的普通技术人员依据本发明的公开内容,均可实现本发明的目的。
本发明的制剂的制备方法包括如下步骤:
(1)制备氧化钙:取石灰石在铂金罐中密封,在1900℃的条件下高温煅烧,冷却后经粉碎成为10-20nm的CaO粉末;
(2)生成具有生物活性的羟基磷灰石:取规格为10-20nm的CaO和P2O5纳米粉末,按照质量比1∶1.67混合均匀为500g的粉末,在36-38℃的情况下,无光条件下陈化至少12小时;加入医用纯净水500g搅拌成糊状,随后加入Na2O2(3g)38℃下搅拌45分钟,过10-20目筛,得到粒径为10-20nm的羟基磷灰石Ca10(PO4)6(OH)2(HA);
(3)向步骤(2)所得羟基磷灰石中加入SiO2(5g)混合均匀后,在-15~-20℃下冻干机冷冻干燥成粉末,并加入医用甘油10g、医用聚乙二醇10g、医用级钛白粉3g、香精1g、卡波姆2-3g、AK糖3g和十二烷基硫酸钠2g,均匀混合;
(4)灭菌:将步骤(3)混合所得膏状体在10℃条件下,辐照灭菌2小时;
(5)干燥:将步骤(4)所得生物制剂,在-15℃条件下冻干成固体状;
(6)粉碎:将该固体粉碎成为20nm的粉末状。
(7)包装:将灭菌膏体灌装在无菌低密度聚乙烯管内,每管质量为60g。
技术效果
临床试验研究报告:含本发明的骨修复生物制剂的牙膏与标准含氟牙膏对减轻牙龈炎症及菌斑效果的临床研究报告
研究人群和方法
本研究为随机、双盲、对照、平行的临床研究。试验牙膏为本发明实施方式的骨修复制剂制成的牙膏,阴性对照标准含氟牙膏。所有牙膏统一包装。所有受试用者使用同一厂家生产的同一型号牙刷。
受试者参加口腔软组织及硬组织检查,龈炎及菌斑检查,按照纳入和排除标准决定实验对象是否入选。
纳入标准:
(1)全身健康状况良好;
(2)年龄在18~70周岁;
(3)如果为女性,不得处于妊娠期和哺乳期内;
(4)改良Quigley-Hein菌斑指数≥1.5;
(5)Loe-Silness龈炎指数≥1.0;
(6)没有同时参加其他类似试验研究。
排除标准:
(1)至少20颗牙无活性龋、冠和V类型修复体;
(2)口腔有明显未治疗龋(肉眼观);
(3)无进展性牙周炎,如超过4mm的牙周袋不超过2个位置;
(4)怀孕或哺乳期;
(5)有全身疾病如中风、结核病、糖尿病、癫痫、传染性疾病(如肝炎)、滥用药物、对牙膏及其他口腔卫生产品过敏;
(6)长期食用抗生素治疗;
(7)戴正畸带环,部分或全口活动义齿,桥修复体超过4颗天然牙;
(8)有严重的牙龈炎和牙周病;
(9)有严重的牙科病变:龋。牙周病、癌前病变、口腔炎性状态;
(10)正在参加其他研究;
(11)对牙膏的成分发生过敏。
共100位研究对象参加了本发明产品的临床研究,将其随机分为试验组与对照组。给受试者统一发放各自相应的牙膏和软质牙刷,要求受试者按规定1日刷牙2次(早、晚),每次时间1min。要求试验过程中不使用任何其他口腔卫生用品,如其他种类的牙膏、牙刷、漱口液、牙线等。对饮食和抽烟不作限制。6周时补充试验的牙膏和牙刷。在使用药膏牙刷6周和12周时,对受试者牙菌斑和牙龈炎状况按照基线检查的程序进行再评估。
在基线、6周和12周评价前8小时不进行口腔清洁。采用改良的Q-H菌斑指数和牙龈指数(Silness&Plaque Index)评价牙周状况。
龈炎指数及检查方法:牙龈炎采用改良Loe-Silness龈炎指数测量,在测量菌斑指数之前测量牙龈情况。牙龈炎计数方法及标准如下:
0=无龈炎
1=轻度龈炎,牙龈色泽和质地略有变化,但探诊无出血
2=中度炎症,牙龈光亮。红、肿,增生、探诊出血
3=重度炎症,牙龈明显发红、增生、有自发性出血
检查每个牙颊面及舌面,除第三磨牙、假牙和有颈部修复体的牙,其余的牙均包括在计数之列。Loe-Silness龈炎指数的均数是指所有牙计数值的总和除以总的测量面数所得数值。
菌斑指数及检查方法:采用Quigley-Hein改良Turesky菌斑指数评价龈上菌斑。牙菌斑染色,首先滴5滴染色剂,用舌头将染色剂布满整个牙面(30秒),含一小口水,在嘱咐受试者含漱30秒,使染色剂充分与牙面接触,清水漱口。使用菌斑染色剂染色后根据下列标准记录:
0=无菌斑
1=牙颈部边缘存在散在的菌斑
2=牙颈边缘可见连续的薄菌斑带(达1mm宽)
3=牙颈部菌斑带大于1mm但少于牙面的1/3
4=菌斑覆盖牙面的1/3-2/3
5=菌斑覆盖牙面2/3以上,
检查每个牙齿的颊面和舌面。出第三磨牙、假牙和有颈部修复体的牙,其余的牙均在记数之列。每一受试者菌斑指数的均数由个人全部牙齿检查所得计数之和除以总的测量数得到。
统计方法:数据采用SPSS16.0统计软件的ANOVA及t检验进行统计分析,采用双侧检验,检验水准a为0.05.
结果:
100位受试者参加本研究,6周检查时随访98例,12周随访96例,失访率为4.0%。试验对象及检查者均没有牙膏副作用的报告,失访的主要原因是外出、生病,使用抗生素等,失访受试者退出本研究的原因与使用研究牙膏无关。试验结果如下:
表1完成研究人群的基线检查结果
*均数±标准差
临床检查结果见表2.
6周检查结果:使用本发明的试验牙膏与对照组比较,6周减少龈上菌斑(PI)和龈炎指数(GI)组间均显示统计学意义的差异(p<0.05)。
12周检查结果:使用本发明的试验牙膏与对照组比较,12周减少龈上菌斑(PI)和龈炎指数(GI)组间均显示统计学意义的差异(p<0.05)。
临床未见副作用报告。
表2菌斑指数(标准差)记分
表3牙龈出血指数(标准差)记分
结论
以上临床研究表明,使用含本发明的骨修复制剂的牙膏与使用对照牙膏相比,具有抑制牙菌斑的形成,减轻牙龈炎,改善牙龈健康的作用。在临床试验期间未观察到牙膏的副作用。
Claims (1)
1.一种具有诱导基因表达的骨生物修复制剂的制备方法,其特征在于所述方法包括如下步骤:
(1)制备氧化钙:取石灰石在铂金罐中密封,在1900℃的条件下高温煅烧,冷却后经粉碎成为10-20nm的CaO粉末;
(2)生成羟基磷灰石:取规格为10-20nm的CaO和P2O5纳米粉末,质量比1∶1.67混合均匀(500g),在36-38℃的情况下,无光条件下陈化至少12小时;加入医用纯净水500g搅拌成糊状,随后加入Na2O2(3g)38℃下搅拌45分钟,过10-20目筛,得到粒径为10-20nm的羟基磷灰石;
(3)向步骤(2)所得羟基磷灰石中加入SiO2(5g)混合均匀后,在-15~-20℃下冷冻干燥成粉末,并加入医用甘油10g、医用聚乙二醇10g、医用级钛白粉3g、香精1g、卡波姆2-3g、AK糖3g和十二烷基硫酸钠2g,均匀混合;
(4)灭菌:将步骤(3)混合所得膏状体在10℃条件下,辐照灭菌2小时;
(5)干燥:将步骤(4)所得的生物制剂,在-15℃条件下冻干成固体状;
(6)粉碎:将该固体粉碎成为20nm的粉末状;
(7)包装:将灭菌膏体灌装在无菌低密度聚乙烯管内,每管质量为60g。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410104328.8A CN104013993B (zh) | 2014-03-20 | 2014-03-20 | 一种具有诱导基因表达的骨生物修复制剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410104328.8A CN104013993B (zh) | 2014-03-20 | 2014-03-20 | 一种具有诱导基因表达的骨生物修复制剂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104013993A true CN104013993A (zh) | 2014-09-03 |
CN104013993B CN104013993B (zh) | 2015-10-07 |
Family
ID=51431171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410104328.8A Active CN104013993B (zh) | 2014-03-20 | 2014-03-20 | 一种具有诱导基因表达的骨生物修复制剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104013993B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105169458A (zh) * | 2015-09-25 | 2015-12-23 | 胡方 | 生物活性矿物质材料及其在软组织溃疡、长期糜烂、伤口细胞再生和抑制黑素瘤的应用 |
CN115737911A (zh) * | 2022-12-16 | 2023-03-07 | 华南理工大学 | 一种高强韧的骨修复复合材料及其制备方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1047627A (zh) * | 1989-06-01 | 1990-12-12 | 河北轻化工学院 | 羟基磷灰石人工骨质材料制备方法 |
CN1103053A (zh) * | 1993-08-19 | 1995-05-31 | 皇星技术(英国)有限公司 | 用作骨骼或牙齿替代物的羟基磷灰石 |
WO1998017236A1 (fr) * | 1996-10-23 | 1998-04-30 | Sunstar Inc. | Preparations orales contenant du verre cristallise biologiquement actif |
WO2003049780A1 (en) * | 2001-12-10 | 2003-06-19 | Tech-Medical S.R.L. | Biocompatible composite material with an osteotropic action |
CN1785155A (zh) * | 2005-11-07 | 2006-06-14 | 陕西科技大学 | 一种生物活性羟基磷灰石牙膏的制备方法 |
CN102245153A (zh) * | 2008-10-08 | 2011-11-16 | 生物薄膜有限公司 | 牙齿再矿化 |
CN102860973A (zh) * | 2012-10-22 | 2013-01-09 | 陈永安 | 修复牙齿损伤的牙膏 |
CN103601166A (zh) * | 2013-11-11 | 2014-02-26 | 陕西科技大学 | 生长在玻璃基片上的纳米棒状羟基磷灰石及其制备方法 |
-
2014
- 2014-03-20 CN CN201410104328.8A patent/CN104013993B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1047627A (zh) * | 1989-06-01 | 1990-12-12 | 河北轻化工学院 | 羟基磷灰石人工骨质材料制备方法 |
CN1103053A (zh) * | 1993-08-19 | 1995-05-31 | 皇星技术(英国)有限公司 | 用作骨骼或牙齿替代物的羟基磷灰石 |
WO1998017236A1 (fr) * | 1996-10-23 | 1998-04-30 | Sunstar Inc. | Preparations orales contenant du verre cristallise biologiquement actif |
WO2003049780A1 (en) * | 2001-12-10 | 2003-06-19 | Tech-Medical S.R.L. | Biocompatible composite material with an osteotropic action |
CN1785155A (zh) * | 2005-11-07 | 2006-06-14 | 陕西科技大学 | 一种生物活性羟基磷灰石牙膏的制备方法 |
CN102245153A (zh) * | 2008-10-08 | 2011-11-16 | 生物薄膜有限公司 | 牙齿再矿化 |
CN102860973A (zh) * | 2012-10-22 | 2013-01-09 | 陈永安 | 修复牙齿损伤的牙膏 |
CN103601166A (zh) * | 2013-11-11 | 2014-02-26 | 陕西科技大学 | 生长在玻璃基片上的纳米棒状羟基磷灰石及其制备方法 |
Non-Patent Citations (1)
Title |
---|
蒙衍强等: "纳米级羟基磷灰石在牙膏中的应用研究", 《日用化学工业》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105169458A (zh) * | 2015-09-25 | 2015-12-23 | 胡方 | 生物活性矿物质材料及其在软组织溃疡、长期糜烂、伤口细胞再生和抑制黑素瘤的应用 |
CN115737911A (zh) * | 2022-12-16 | 2023-03-07 | 华南理工大学 | 一种高强韧的骨修复复合材料及其制备方法 |
CN115737911B (zh) * | 2022-12-16 | 2024-06-21 | 华南理工大学 | 一种高强韧的骨修复复合材料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104013993B (zh) | 2015-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Madeswaran et al. | Sodium bicarbonate: A review and its uses in dentistry | |
Zanata et al. | Effect of caries preventive measures directed to expectant mothers on caries experience in their children | |
Meyer-Lueckel et al. | Caries management: science and clinical practice | |
Fung et al. | Early childhood caries: a literature review | |
Ritter et al. | Dental caries: etiology, clinical characteristics, risk assessment, and management | |
CN108652993A (zh) | 一种口腔护理组合物及其应用 | |
Waikhom et al. | Antimicrobial effectiveness of Nano Silver Fluoride Varnish in reducing Streptococcus mutans in saliva and plaque biofilm when compared with Chlorhexidine and Sodium Fluoride Varnishes | |
Rapp et al. | Dental caries in geriatric dentistry: an update for clinicians | |
CN104013993B (zh) | 一种具有诱导基因表达的骨生物修复制剂的制备方法 | |
CN104013539B (zh) | 一种具有诱导基因表达的骨修复牙膏膏剂的制备方法 | |
Meyer et al. | Caries etiology and preventive measures | |
Thaweboon et al. | Remineralizaron of enamel subsurface lesions by xylitol chewing gum containing funoran and calcium hydrogenphosphate. | |
Kishen et al. | Broccoli and its anti cariogenic effect-review | |
Kade et al. | Comparative Evaluation of the Remineralization Potential of Fluoride-containing Toothpaste, Honey Ginger Paste and Ozone. An In Vitro Study | |
Ali et al. | Effect of application of natural versus synthetic desensitizing agents on dentin permeability | |
Jumanca et al. | The Effect of Hydroxyapatite from Various Toothpastes on Tooth Enamel | |
Hume | Restorative Dentistry: Current Status and Future Directions. | |
Raj | Molar Incisor Hypomineralisation: A Study of Prevalence and Etiology in Children Aged 7-12 Years in Bengaluru City | |
BALASUBRAMANIAM et al. | Association between Gender and Plaque Index-A Retrospective analysis of 86,000 patient records over nine months | |
Abdelhamid Arafa et al. | EVALUATION OF SILVER DIAMINE FLUORIDE AS NON-INVASIVE TREATMENT ON DENTIN REMINERALIZATION OF CARIOUS PRIMARY MOLARS (AN IN VITRO STUDY) | |
Mahammadovna et al. | Treatment Of Dental Caries In Children And Adolescents | |
LEELAVATHI et al. | Prevalence Of Wasting Disease Among Hypertensive And Diabetic Patients-An Institutional Study. | |
Valentina et al. | Modern methods of diagnosis and treatment of deep caries | |
Al Wadei | A KNOWLEDGE ATTITUDE AND OPINION TOWARDS BIOMIMETIC MATERIALS USED IN CONSERVATIVE DENTISTRY AND ENDODONTICS AMONG DENTISTS | |
Sezen et al. | Effect of 38% silver diamine fluoride on fracture resistance of leucite reinforced feldspathic ceramic CAD/CAM class I inlay restorations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180320 Address after: 100092 Yongtai Zhuang Bei Road, Haidian District, Haidian District, Beijing, Yat Park B2 Patentee after: Beijing happy Hi Tech Co., Ltd. Address before: 100037, B2308, 72 century west economic and trade building, West Third Ring Road, Beijing, Haidian District Patentee before: Hu Fang |
|
TR01 | Transfer of patent right |